Welcome to our dedicated page for Archimedes Tech SPAC Partners II Co. SEC filings (Ticker: ATIIU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Archimedes Tech SPAC Partners II Co. filings document material-event reporting for a Cayman Islands blank-check company with ordinary shares and warrants listed on Nasdaq. The company’s 8-K disclosures cover material definitive agreements, shareholder voting matters, capital-structure information, SPAC security-structure disclosures, risk factors, and operating and financial results.
The filing record focuses on the formal mechanics of a SPAC issuer, including governance actions and securities disclosures connected to its units, ordinary shares, and warrants.
Barclays PLC reports beneficial ownership of 1,864,405 shares of Archimedes Tech SPAC Partner common stock, representing 6.30% of the class. The filing shows Barclays has sole voting and dispositive power over 1,864,400 shares and shared voting and dispositive power over 5 shares, indicating control over the vast majority of its disclosed stake.
Barclays is classified as an HC (parent holding company) and identifies Barclays Bank PLC and Barclays Capital Securities Ltd as the subsidiaries that acquired the securities. The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not to change or influence control.
Archimedes Tech SPAC Partners II Co. is a blank-check company that completed its IPO on February 12, 2025, selling 23,000,000 Units (including a full 3,000,000-unit over-allotment) at $10.00 per Unit for gross proceeds of $230,000,000 and a simultaneous private placement of 840,000 Units for $8,400,000.
As of June 30, 2025 the company reports total assets of $236,897,701, comprised of $234,944,821 held in a Trust Account and $1,764,859 of cash outside the trust. Total liabilities are $8,209,120, including a deferred underwriting fee payable of $8,050,000. Ordinary shares subject to possible redemption (23,000,000 shares) are reflected at a redemption value of $234,944,821, producing shareholders' deficit of $(6,256,240).
The company had net income of $2.36 million for the quarter and $3.52 million for the six months ended June 30, 2025, driven by interest earned on trust assets of $2.49 million and $3.79 million, respectively, offset by general and administrative expenses of $130,359 and $277,020. The Company has not commenced operations, has not selected a Business Combination target, and must complete a Business Combination within the 21-month completion window or effect liquidation as described in its charter.